Health Insurance as Innovation Incentive image

Jotwell, June 9, 2016
Amy Monahan, reviewing paper by Rachel E. Sachs (Academic Fellow)

Links

Read the Full Article

Excerpt from the article:

In Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, Rachel Sachs brings together the often disparate worlds of intellectual property theory and health insurance design, to argue that prescription drug insurance could be structured to offer a better incentive for pharmaceutical companies to develop drugs that treat conditions primarily affecting low-income Americans. Typically, health insurance design is evaluated from an access and utilization perspective. Professor Sachs suggests we should broaden that view, at least when it comes to drug coverage, to evaluate the effect insurance coverage has on research and development incentives. [...]

innovation insurance pharmaceuticals rachel sachs